Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yamashita Health Care HoldingsTSE:9265 +0.13%71 Return-on-Tangible-Asset is 4.84% as of Feb. 2026, which is 111% above its 10-year median of 2.29. GuruFocus rates TSE:9265 with a GF Score™ of 71/100 and a GF Value™ of 円2,960.03 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 120 Medical Distribution companies, Yamashita Health Care Holdings ranks better than 50.83% on this metric.
The historical rank and industry rank for Yamashita Health Care Holdings's Return-on-Tangible-Asset or its related term are showing as below:
TSE:9265'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.71 Med: 2.29 Max: 2.99
Current: 2.5
During the past 9 years, Yamashita Health Care Holdings's highest Return-on-Tangible-Asset was 2.99%. The lowest was 0.71%. And the median was 2.29%.
TSE:9265's Return-on-Tangible-Asset is ranked better than 50.83% of 120
companies
in the Medical Distribution industry
Industry Median: 2.43
vs TSE:9265: 2.50
Yamashita Health Care Holdings (TSE:9265) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Yamashita Health Care Holdings Return-on-Tangible-Asset Related Terms
Yamashita Health Care Holdings Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings Return-on-Tangible-Asset Chart
TSE:9265 vs MCK, COR, CAH: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Yamashita Health Care Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Feb. 2026) net income data.
What does a Return-on-Tangible-Asset of 4.84% mean?
Yamashita Health Care Holdings (TSE:9265) has a Return-on-Tangible-Asset of 4.84% as of Feb. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Yamashita Health Care Holdings and its competitors. This is 111% above median its historical median of 2.29. Over the past decade, Yamashita Health Care Holdings' Return-on-Tangible-Asset has ranged from 0.71 to 2.99. According to the industry distribution chart, Yamashita Health Care Holdings ranks #59 out of 120 companies in the Medical Distribution industry, placing it in the top 49.2%.
Is Yamashita Health Care Holdings' Return-on-Tangible-Asset too high?
Yamashita Health Care Holdings' current Return-on-Tangible-Asset of 4.84% is 111% above median its 10-year median of 2.29. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 2.99. The Medical Distribution industry median Return-on-Tangible-Asset is 2.43. Yamashita Health Care Holdings' value of 4.84% is 99.2% above this industry median. Based on the distribution chart, Yamashita Health Care Holdings ranks #59 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Yamashita Health Care Holdings has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' Return-on-Tangible-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #59 out of 120 companies for Return-on-Tangible-Asset. This puts Yamashita Health Care Holdings in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.43. Yamashita Health Care Holdings' value of 4.84% is 99.2% above this benchmark. Historically, Yamashita Health Care Holdings' own Return-on-Tangible-Asset has ranged from 0.71 to 2.99 over the past decade. While the company's 10-year median is 2.29 vs. the industry median of 2.43, Yamashita Health Care Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.43, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current Return-on-Tangible-Asset of 4.84% is 99.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Yamashita Health Care Holdings and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current Return-on-Tangible-Asset is 4.84%, which is 111% above median its own 10-year median of 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,960.03, compared to a current price of 円3,710.00 — trading 25.3% above its estimated fair value. The current Return-on-Tangible-Asset is 4.84%, which is 111% above median its 10-year median of 2.29 and 99.2% above the Medical Distribution industry median of 2.43. Yamashita Health Care Holdings' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current Return-on-Tangible-Asset is 4.84% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,710.00 is trading 25.3% above its estimated GF Value™ of 円2,960.03.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
Return-on-Tangible-Asset: 4.84% (111% above median its 10-year median of 2.29)
GF Value™: 円2,960.03 vs. price of 円3,710.00 (25.3% above fair value)
Industry Position: 99.2% above the Medical Distribution median (#59 of 120)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
71GF Score
Get the complete analysis for TSE:9265
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
